Biotech

All Articles

Lilly, Haya ink $1B biobuck being overweight deal to search dark genome

.Eli Lilly's hunt for obesity aim ats has led it to the dark genome. The Big Pharma has produced a d...

ArsenalBio raises $325M, turns far from past lead asset

.Toolbox Biosciences is actually proceeding up. The cell therapy company has actually added on $325 ...

Lilly- supported fat burning biotech files IPO

.After increasing $170 million back in February, metabolic disease-focused BioAge Labs has actually ...

Aelis' marijuana make use of medicine fails period 2b, steering Indivior to re-think $100M option

.Aelis Farma's hopes of protecting a simple, good choice on a $one hundred million alternative repay...

ProKidney standstills stage 3 trial certainly not required for tissue treatment permission

.ProKidney has actually quit one of a set of stage 3 tests for its own tissue therapy for renal heal...

Vaxcyte surges on 'stunning' 31-valent PCV gain versus Pfizer

.Vaxcyte unveiled what experts referred to as "impressive" stage 1/2 records for its own 31-valent p...

Recursion's human brain condition test reveals little evidence of efficiency

.Recursion has actually stumbled with a very early exam of its own tech-enabled method to medicine e...

Acepodia, Pfizer click on with each other for chemistry-based tissue treatment

.Phone it a scenario of good chemistry: Acepodia, a biotech based upon Nobel Prize-winning science, ...

Praxis epilepsy medication lessens confiscations in period 2 litigation

.Practice Preciseness Medicines has actually racked up yet another midphase gain in epilepsy this ye...

Three execs resign as Dyne posts combined records for DMD applicant

.After leaving a clinical grip several years back, Dyne Therapy has uncovered new stage 1/2 data for...